Concepedia

Publication | Closed Access

High dosage rifaximin for the treatment of small intestinal bacterial overgrowth

DOI

111

Citations

13

References

2007

Year

Emidio Scarpellini, Maurizio Gabrielli, C. Lauritano, A. Lupascu, Giuseppe Merra, Giovanni Cammarota, I.A. Cazzato, Antonio Gasbarrini
Alimentary Pharmacology & Therapeutics

Abstract

Rifaximin 1600 mg/day showed a significantly higher efficacy for small intestinal bacterial overgrowth treatment with respect to 1200 mg with similar compliance and side-effect profile.

References

YearCitations

Page 1